Background
==========

Aerogen is currently developing drug/device combinations for delivery of drug to the lungs of mechanically ventilated patients with efficiencies above 60%. When therapy needs to continue post extubation, an aerosol delivery device of similar efficiency is required to deliver the same drug dose. Commercially available nebulizers with inhaled mass ranging from 6 to 30% would require several doses to achieve the same inhaled mass. We modified the pulmonary drug delivery system (PDDS; Aerogen) to provide similar drug delivery efficiencies to patients on and off the ventilator.

Methods
=======

Three PDDS units were used to aerosolize albuterol sulfate (2.5 mg) to simulated patients in both on vent and off vent configurations (*n*= 3). On vent was simulated with a Puritan Bennett 740 Ventilator with tidal volume of 500 ml, peak flow 40 l/min, ramp flow pattern, I:E ratio 1:2, and rate of 15 breaths/min through an 8-mm endotracheal tube attached to a passive lung model (Ingmar). The off vent configuration consisted of an adult lung simulator (Hans Rudolph) with a tidal volume of 500 ml, peak flow 28 l/min, and I:E ratio 1:2. The amount of drug deposited on an absolute filter distal to the endotracheal tube and mouthpiece was eluted and determined by reverse-phase HPLC with isocratic elution and UV detection at 275 nm. The volume median diameter (VMD) and geometric standard deviation of the aerosol were determined by laser diffraction (Spraytech™ Malvern).

Results
=======

The percentage of total dose ± standard deviation delivered to the test lung was 72 ± 11% on vent and 70 ± 0.3% off vent. The mean VMD was 3.5 μm with a GSD of 2.1.

Summary
=======

Our *in vitro*results demonstrate that it is feasible to provide comparable high-efficiency aerosol delivery to adult patients whether on or off the ventilator. Additional studies with the PDDS *in vivo*will be required to establish the *in vitro*/*in vivo*correlations of this model.

Conclusion
==========

The Aerogen PDDS delivered \> 60% of the total dose to the airway of simulated adult patients during mechanical ventilation and spontaneous breathing.
